Nanalysis Scientific Corp (NSCI) Fair Value & Analysis
Technology · CA · Market cap C$17.3M
Fair value as of: Jun 26, 2026
From 7 valuation models · updated 4 days ago
Fair value updated Jun 26, 2026 — revised from C$0.2900 to C$0.0400 (−86.2%) since Jun 24, 2026. Share price −7.1% over the past month.
Price vs Fair Value (12 months)
12‑month range C$0.1246 – C$0.2596 · fair‑value band C$0.0400 – C$0.0800 · the C$0.1350 price screens above the C$0.0400 fair value. As of Jun 26, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Nanalysis Scientific Corp (NSCI) currently trades at C$0.1350, while our model-based Fair Value estimate is C$0.0400 — implying the stock looks roughly 70.4% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Nanalysis Scientific Corp generated revenue of C$40.2M at a net margin of -14.0%. Revenue grew 0.7% year over year. It earns a return on equity of -41.4%. Net debt stands at C$15.4M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100-NMR platform; 60-TEACH; QUAD NMR Console; and the Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, a user interface for data acquisition and processing of benchtop NMR products; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security services, including preventive and on-call maintenance services, scheduled preventative mainte…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Nanalysis Scientific Corp reported revenue of C$40.1M in FY2025 versus C$16.0M in FY2021, a compound +25.8%/yr. Reported net income was −C$5.7M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Keyence Corporation KYCCF | $470.00 | $229.05 | -51% |
| Keysight Technologies, Inc KEYS | $329.83 | $92.23 | -72% |
| Garmin Ltd GRMN | $236.34 | $162.20 | -31% |
| Chroma ATE Inc 2360 | 2,265 TWD | 278.23 TWD | -88% |
| Teledyne Technologies Incorporated TDY | $601.35 | $358.39 | -40% |
| Hexagon AB HXGBF | $8.84 | $5.23 | -41% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Nanalysis Scientific Corp (NSCI) undervalued?
What is the fair value of NSCI?
What is the quality score of NSCI?
What is the revenue of Nanalysis Scientific Corp (NSCI)?
What is the net profit margin of NSCI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.